Regional Dengue Symposium Addresses Today’s Challenges in Dengue Control

RIO DE JANEIRO, BRAZIL — November 3, 2015 — More than one hundred public health experts and stakeholders gathered today in Rio de Janeiro, Brazil, for the First Regional Dengue Symposium, led by the Pan American Health Organization (PAHO), the Sabin Vaccine Institute (Sabin) and the Dengue Vaccine Initiative (DVI).
11.03.15 to 11.04.15
Rio de Janeiro, Brazil

On October 13, Mike McQuestion, Director of Sabin’s Sustainable Immunization Financing (SIF) program, spoke to officials in the parliament in Tbilisi, Georgia, lauding the country’s impressive performance on immunization and calling for other countries to follow its example.

Dr. Sazaly has been involved with dengue research for over 20 years and has also maintained strong research interest in emerging infectious diseases. His interest in dengue, in particular, is rooted in its knowledge gaps: “it is a fascinating disease needing a lot more research to take on.” In an interview with DVI, Dr. Sazaly shares more on his views of dengue prevention and control and needs in the dengue research field.

In countries around the world, cadres of information specialists work behind the scenes, tracking expenditures and keeping immunization managers informed of financial matters. They play a crucial part in helping to ensure that all people have access to vaccines. In Cameroon, Mr.

by Peter Hotez, M.D., Ph.D. Hotez is Dean of the National School of Tropical Medicine at Baylor College of Medicine where he is also the Texas Children’s Hospital Endowed Chair in Tropical Pediatrics and the University Professor of Biology at Baylor University.

Smallpox was one of the most terrifying diseases in human history. Smallpox plagued humanity for thousands of years, killing one-third of its victims and disfiguring those who survived.


Subscribe to RSS - Vaccine Advocacy and Education